comparing three different doses of intranasal dexmedetomidine to reduce the patient stress after airway pipe insertio
Not Applicable
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2023/09/057412
- Lead Sponsor
- DEPARTMENT OF ANAESTHESIA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Age group: 18-60 years.
2.ASA (American Society of Anaesthesiologists) physical status I and II.
3.Elective surgeries under GA with endotracheal intubation.
Exclusion Criteria
1.Patient with any anticipated difficult airway.
2.Patients suffering from significant cardiac, respiratory and renal disease.
3.Patient with nasal ulcers, polyps, nasal septum deviation.
4.Patient’s refusal to give consent.
5.Patient with known allergy or hypersensitivity to dexmedetomidine.
6.Patients with BMI > 35kg/m2.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Among three groups of intranasal dexmedetomidine probabaly 2mcg/kg may be more suitable.Timepoint: 60 minutes.
- Secondary Outcome Measures
Name Time Method Because of its mild to moderate sedation effect peri operative patient well being will be better.Timepoint: 24hours